In the run-up to the Arab Health 2024 conference, Genopole® is organising a morning session to raise awareness among biotech companies of the business opportunities in healthcare in the Arabian Peninsula and Gulf markets.
The United Arab Emirates is currently one of the most dynamic healthcare markets in the world. Indeed, local demand for medical equipment goes beyond the domestic market, with the Emirates serving as a platform for re-exports to neighbouring countries.
Seed and Series A financing opportunities are also available for French companies.
ARAB HEALTH is now the leading trade fair for the sector in the Near and Middle East.
Program
- General Presentation of economic perspectives in Middle-East: PESTEL Analysis, healthcare, foodtech and agroalimentary sectors, Market Sizes / Opportunities…
- Focus on Saudis and Emiratis market access: Healthcare City et Dubai Science Park, Regulation: presentation of the SFDA, major research and transition programmes, funding and start-up acceleration opportunities with Betalab (Saudi biocluster – Genopole partner)
- The environment for start-ups: new technologies and AI, financing and development policies, etc.
- Q&A session
- Networking over a cocktail lunch
Venue
Salle Elyséum – GIP Genopole
20 rue Henri Desbruères
91000 EVRY-COURCOURONNES – France
The morning is also available online.
Registration is free, but is compulsory in order to welcome you ☺️
